Insights

Global Expansion Biogen has announced plans to establish a new global headquarters and innovation hub in Kendall Square by 2028. This move centralizes the company's operations, presenting an opportunity for strategic partnerships and collaborations for sales growth.

Clinical Development Biogen is actively conducting Phase III studies for felzartamab in kidney transplant recipients diagnosed with late antibody-mediated rejection (AMR). Engaging with healthcare providers or institutions involved in similar research areas could lead to potential sales opportunities for the drug upon successful completion.

Diversification Strategy With a focus on developing new treatments beyond its existing product portfolio, Biogen aims to counter declining revenues from key drugs like Tecfidera and Tysabri. Sales representatives can explore partnerships for marketing, distribution, or licensing of new therapies to diversify revenue streams.

Market Competitive Analysis Despite challenges in MS drug sales and revenue decline in 2024, Biogen remains competitive among similar biotech companies. Sales professionals can leverage this competitive positioning to offer innovative solutions and solidify Biogen's market presence through strategic sales tactics.

Funding Opportunities Biogen's financial standing with a reported revenue of $1 billion and funding of $1.5 billion offers stability and potential for investment. Sales development representatives can target investors or financial institutions for collaborations or explore avenues for expanding product lines backed by secure funding.

Biogen Tech Stack

Biogen uses 8 technology products and services including SAP, PlanView, Microsoft Outlook, and more. Explore Biogen's tech stack below.

  • SAP
    Customer Relationship Management
  • PlanView
    Digital Asset Management
  • Microsoft Outlook
    Email
  • SchedulePro
    Human Resource Management System
  • GitLab
    Issue Trackers
  • Wireshark
    IT Infrastructure Monitoring
  • Microsoft Word
    Office Suites
  • JSON
    Programming Languages

Media & News

Biogen's Email Address Formats

Biogen uses at least 2 format(s):
Biogen Email FormatsExamplePercentage
First.Last@biogen.comJohn.Doe@biogen.com
85%
First_Last@biogen.comJohn_Doe@biogen.com
13%
F.Last@biogen.comJ.Doe@biogen.com
1%
First.Middle@biogen.comJohn.Michael@biogen.com
1%
First.Last@biogenidec.comJohn.Doe@biogenidec.com
95%
Last@biogenidec.comDoe@biogenidec.com
2%
First_Last@biogenidec.comJohn_Doe@biogenidec.com
1%
FirstMiddle.Last@biogenidec.comJohnMichael.Doe@biogenidec.com
1%
FirstLast@biogenidec.comJohnDoe@biogenidec.com
1%

Frequently Asked Questions

Where is Biogen's headquarters located?

Minus sign iconPlus sign icon
Biogen's main headquarters is located at 225 Binney Street Cambridge, MA 02142 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Biogen's phone number?

Minus sign iconPlus sign icon
You can contact Biogen's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Biogen's stock symbol?

Minus sign iconPlus sign icon
Biogen is a publicly traded company; the company's stock symbol is BIIB.

What is Biogen's official website and social media links?

Minus sign iconPlus sign icon
Biogen's official website is biogen.com and has social profiles on LinkedIn.

How much revenue does Biogen generate?

Minus sign iconPlus sign icon
As of April 2025, Biogen's annual revenue reached $9.8B.

What is Biogen's SIC code NAICS code?

Minus sign iconPlus sign icon
Biogen's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does Biogen have currently?

Minus sign iconPlus sign icon
As of April 2025, Biogen has approximately 7.7K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: T. P.Chief Executive Officer: A. A.Chief Information Security Officer: R. K.. Explore Biogen's employee directory with LeadIQ.

What industry does Biogen belong to?

Minus sign iconPlus sign icon
Biogen operates in the Biotechnology Research industry.

What technology does Biogen use?

Minus sign iconPlus sign icon
Biogen's tech stack includes SAPPlanViewMicrosoft OutlookScheduleProGitLabWiresharkMicrosoft WordJSON.

What is Biogen's email format?

Minus sign iconPlus sign icon
Biogen's email format typically follows the pattern of . Find more Biogen email formats with LeadIQ.

How much funding has Biogen raised to date?

Minus sign iconPlus sign icon
As of April 2025, Biogen has raised $1.5B in funding. The last funding round occurred on Aug 28, 2023 for $1.5B.
Biogen

Biogen

Biotechnology ResearchMassachusetts, United States5001-10000 Employees

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. 

We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.

With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.

For more information, please visit www.biogen.com. Community Guidelines: https://www.biogen.com/community-guidelines.html

Follow us on social media –  LinkedIn, Facebook, X, and YouTube.

Section iconCompany Overview

Headquarters
225 Binney Street Cambridge, MA 02142 US
Phone number
Website
biogen.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
BIIB
NAICS Code
325412 - Pharmaceutical Preparation Manufacturing
Employees
5001-10000

Section iconFunding & Financials

  • $1.5B

    Biogen has raised a total of $1.5B of funding over 1 rounds. Their latest funding round was raised on Aug 28, 2023 in the amount of $1.5B.

  • $1B

    Biogen's revenue is in the range of $1B

Section iconFunding & Financials

  • $1.5B

    Biogen has raised a total of $1.5B of funding over 1 rounds. Their latest funding round was raised on Aug 28, 2023 in the amount of $1.5B.

  • $1B

    Biogen's revenue is in the range of $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.